In conclusion, our results demonstrate that FPR2 has anti-inflammatory roles in the liver and that its sex-specific expression is closely related to sex disparities in NAFLD/NASH development. This evidence concerns the gene FPR2 and metabolic dysfunction-associated steatohepatitis.